0001437749-16-040312.txt : 20161026 0001437749-16-040312.hdr.sgml : 20161026 20161026140644 ACCESSION NUMBER: 0001437749-16-040312 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20161024 FILED AS OF DATE: 20161026 DATE AS OF CHANGE: 20161026 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 125 SHOREWAY ROAD STREET 2: SUITE B CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOYES JAY M CENTRAL INDEX KEY: 0001191062 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21419 FILM NUMBER: 161952209 3 1 rdgdoc.xml FORM 3 X0206 3 2016-10-24 0 0000925741 BioCardia, Inc. BCDA 0001191062 MOYES JAY M C/O BIOCARDIA, INC. 125 SHOREWAY ROAD, SUITE B SAN CARLOS CA 94070 1 Common Stock 159009 I See footnote Director stock option (right to buy) 0.1300 2020-11-11 Common Stock 162941 D Director stock option (right to buy) 0.1300 2020-12-23 Common Stock 54307 D These shares are held by Drayton Investments LLC, for which the Reporting Person serves as a managing member. The shares subject to the option are fully vested and immediately exercisable. Exhibit 24 – Power of Attorney /s/ Peter Altman, by power of attorney 2016-10-26 EX-24 2 moyespoa.htm MoyesPOA.htm

 Exhibit 24

 

LIMITED POWER OF ATTORNEY — SECURITIES LAW COMPLIANCE

 

 

The undersigned, as a Section 16 reporting person of Tiger X Medical, Inc. (the “Company”), hereby constitutes and appoints Peter Altman and David McClung, and each of them, as the undersigned’s true and lawful attorneys-in-fact, to:

 

1.      Complete and execute Forms 3, 4 and 5 and other forms and all amendments thereto as such attorneys-in-fact shall in their discretion determine to be required or advisable pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned’s ownership, acquisition or disposition of securities of the Company; and

 

2.      Do all acts necessary in order to file such forms with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate.

 

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agent shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 30th day of September, 2016.

 

 

 

 

Signature:

/s/ Jay M. Moyes 

 

 

 

 

 

 

Print Name:

Jay M. Moyes